PAVmed Inc. (PAVM) Stock
Healthcare · Medical Devices · Member of Other US Stocks
PAVmed Inc. (PAVM) closed at USD 2.29 on 2026-10-14, a change of -82.4 % over the past year, with a market capitalization of USD 19.39M.
PAVmed Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 2.29 |
| 2026-10-13 | 2.64 |
| 2026-10-12 | 2.69 |
| 2026-10-09 | 2.79 |
| 2026-10-08 | 2.69 |
| 2026-10-07 | 2.74 |
| 2026-10-06 | 2.67 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
PAVmed Inc. key figures
- Previous close
- USD 2.29 (2026-10-14)
- 1-year change
- -82.4 %
- Market cap
- USD 19.39M
- Enterprise value
- USD 18.06M
- P/E ratio (trailing)
- -0.19
- P/E ratio (forward)
- -1.02
- EPS (trailing)
- -12.69
- EPS (forward)
- -2.38
- PEG ratio
- n/a
- Price to book
- 0.49
- Revenue growth
- 450 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.52
- Employees
- 41
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About PAVmed Inc.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for PAVmed Inc. and compare it with other stocks.
Analyze PAVMAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell PAVmed Inc. shares.